CD169+ sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer
Open Access
- 27 February 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (9) , 10199-10211
Abstract
Aims: Mismatch‐repair deficiency and microsatellite instability‐high (dMMR/MSI‐H) colorectal cancer (CRC) is treated with programmed death (PD)‐1 antibody regardless of PD‐ligand (L)1 expression in tumor cells. We previously found that abundant CD169+ macrophages in regional lymph node (RLN) sinuses and CD8+ tumor‐infiltrating lymphocytes (TILs) positively correlated in CRC and were associated with a favorable prognosis. However, associations between dMMR/MSI‐H CRC and CD8+ TILs or prognoses vary among studies. In this study, we attempted to compare the association between MMR status, CD169+ macrophages in RLNs, CD8+ TILs, PD‐L1 scores, and prognoses in CRC.Methods and Results: We immunostained 83 surgically resected CRC tumors that we previously analyzed for MMR proteins, and identified 9 that were dMMR. The number of CD169+ macrophages in RLNs and CD8+ TILs significantly correlated with overall survival, whereas MMR status did not. The number of cells positive for the TIL markers CD3, CD4, CD8, and TIA‐1, and macrophage markers CD68 and CD169 in RLNs did not significantly differ between groups according to MMR status. Furthermore, combined positive scores (CPS) for PD‐L1 expression in five of nine dMMR CRCs were all + macrophages in RLNs or CD8+ TILs.Conclusions: CRC with CD169+ macrophages in RLNs and abundant CD8+ TILs indicates a better prognosis and it should be immunologically classified as a different antitumor group from dMMR CRC.Keywords
This publication has 51 references indexed in Scilit:
- CD169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinomaCancer Science, 2013
- Lymph Node MacrophagesJournal of Innate Immunity, 2012
- CD169+ macrophages at the crossroads of antigen presentationTrends in Immunology, 2012
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated AntigensImmunity, 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer SyndromeAmerican Journal of Surgical Pathology, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- The multifaceted mismatch-repair systemNature Reviews Molecular Cell Biology, 2006
- PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T CellsCancer Research, 2004
- Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigensInternational Journal of Cancer, 2001